Danville, California
United States
27
2025-01-30
The entities that hold a legal rights for patent applications filed by inventor Moore Stephen James:
Stephen James Moore from Danville, US has applied for patents for these inventions. The list has both pending applications and granted patents:
PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF MAKING AND USING THEREOF
#2 | 2024-05-09MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF
#3 | 2024-05-09MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF
#4 | 2024-03-14MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF
#5 | 2023-07-06MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#6 | 2023-01-19Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#7 | 2022-12-29Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#8 | 2022-12-01Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#9 | 2022-10-18Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#10 | 2022-09-22ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF
#11 | 2022-07-28Protease-resistant systems for polypeptide display and methods of making and using thereof
#12 | 2021-11-18MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#13 | 2021-11-11MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#14 | 2021-01-28METHODS OF QUALITATIVELY AND/OR QUANTITATIVELY ANALYZING PROPERTIES OF ACTIVATABLE ANTIBODIES AND USES THEREOF
#15 | 2020-10-29Protease-resistant systems for polypeptide display and methods of making and using thereof
#16 | 2020-07-23Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
#17 | 2019-12-19Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
#18 | 2019-09-19Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
#19 | 2019-08-08MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#20 | 2019-05-09Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#21 | 2017-07-20Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#22 | 2017-01-05Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
#23 | 2016-10-27Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof
#24 | 2016-10-06Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#25 | 2016-09-15Protease-resistant systems for polypeptide display and methods of making and using thereof
#26 | 2015-08-06Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#27 | 2015-03-26Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use Thereof
1112332 ⎘